| Dr Arshan Beyzaei Arani, MD | |
|
2501 Parkers Ln, Alexandria, VA 22306-3209 | |
| (703) 664-7141 | |
| (703) 664-7089 |
| Full Name | Dr Arshan Beyzaei Arani |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 20 Years |
| Location | 2501 Parkers Ln, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134300148 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Mount Vernon Hospital | Alexandria, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Health Care Services | 2466351093 | 1725 |
News Archive
A U.S. Food and Drugs Administration (FDA) panel, this Thursday agreed that a new drug Vivitrol helps alcoholics and opioid addicts kick the habit. The panel voted 11 to 2 that there was sufficient evidence from a single clinical trial that Vivitrol is effective when it comes to helping people addicted to painkillers.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
› Verified 6 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20110104000695 |
News Archive
A U.S. Food and Drugs Administration (FDA) panel, this Thursday agreed that a new drug Vivitrol helps alcoholics and opioid addicts kick the habit. The panel voted 11 to 2 that there was sufficient evidence from a single clinical trial that Vivitrol is effective when it comes to helping people addicted to painkillers.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
› Verified 6 days ago
| Entity Name | Commonwealth Critical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891210035 PECOS PAC ID: 4284909029 Enrollment ID: O20171004003466 |
News Archive
A U.S. Food and Drugs Administration (FDA) panel, this Thursday agreed that a new drug Vivitrol helps alcoholics and opioid addicts kick the habit. The panel voted 11 to 2 that there was sufficient evidence from a single clinical trial that Vivitrol is effective when it comes to helping people addicted to painkillers.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arshan Beyzaei Arani, MD Po Box 37174, Baltimore, MD 21297-3174 Ph: (571) 423-5699 | Dr Arshan Beyzaei Arani, MD 2501 Parkers Ln, Alexandria, VA 22306-3209 Ph: (703) 664-7141 |
News Archive
A U.S. Food and Drugs Administration (FDA) panel, this Thursday agreed that a new drug Vivitrol helps alcoholics and opioid addicts kick the habit. The panel voted 11 to 2 that there was sufficient evidence from a single clinical trial that Vivitrol is effective when it comes to helping people addicted to painkillers.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Cellular Biomedicine Group, Inc., a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, is pleased to announce that it has treated the final patient of its Phase I clinical trial which evaluates the safety and preliminary efficacy of TC-DC (Tumor Stem Cell Specific Dendritic Cell) therapy for hepatocellular carcinoma, the most common type of liver cancer.
› Verified 6 days ago
George Peter Silis, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5115 Franconia Road, Sutie G, Alexandria, VA 22310 Phone: 703-922-4222 Fax: 703-922-4253 | |
Dr. Madhusudanan Srambickal Ramaswamy, M.D., M.S. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Seminary Rd, Alexandria, VA 22304 Phone: 703-504-3000 Fax: 571-285-0027 | |
Nabeela Tabassum, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 4810 Beauregard St, Ste 303, Alexandria, VA 22312 Phone: 703-750-0108 Fax: 703-750-0230 | |
Dr. Chinedu Madu, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4825 Mark Center Dr Ste 150, Alexandria, VA 22311 Phone: 703-751-8111 Fax: 703-751-1105 | |
Kim-dung T Nguyen, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 5130 Duke St, 8, Alexandria, VA 22304 Phone: 703-823-2849 Fax: 703-823-2847 | |
Dr. Muhammed F. Khokhar, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave Ste 810, Alexandria, VA 22304 Phone: 703-823-0333 Fax: 703-823-8611 | |
Tariq Rehman, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 4141a Duke St, Alexandria, VA 22304 Phone: 703-461-3556 Fax: 703-461-8075 |